Southeastern Health Regional Observatory (Observatoire régional de la santé Paca), Marseille, France; Inserm, F-CRIN, Innovative Clinical Research Network in VACcinology (I-REIVAC), Paris, France.
Centre hospitalo-universitaire, Clermont-Ferrand, Centre d'Investigation Clinique, INSERM, CIC1405, Clermont-Ferrand, France; Inserm, F-CRIN, Innovative Clinical Research Network in VACcinology (I-REIVAC), Paris, France.
Vaccine. 2021 Jul 22;39(32):4481-4488. doi: 10.1016/j.vaccine.2021.06.053. Epub 2021 Jun 29.
Healthcare professionals, because they recommend vaccines to their patients, answer their questions, and vaccinate them, are the cornerstone of vaccination in France. They can nonetheless be affected by vaccine hesitancy (VH).
We sought to study the opinions, practices, and perceptions of French hospital staff physicians (HSPs) toward vaccination and the prevalence and correlates of VH among them.
We conducted a cross-sectional survey in 14 public hospitals in France from September 2018 to October 2019. HSPs completed a standardized questionnaire -most of the time face-to-face - about their vaccine-related attitudes and practices. Data were weighted for age and sex. An agglomerative hierarchical cluster analysis of the HSPs' perceptions and opinions toward vaccination allowed us to identify vaccine-hesitant HSPs, and multiple Poisson regression with robust standard errors let us study the factors associated with VH.
The study included 1,795 HSPs (participation rate: 86%). Almost all (93.7%) were strongly favorable to vaccination, even though 42.2% (95CI = 39.8-44.6) showed moderate VH. VH prevalence was lowest among infectious disease specialists (12.3%; 95CI = 6.7-21.3) and pediatricians (27.7%; 95CI = 21.4-35.2). Hesitant HSPs were less trustful of vaccination information sources and doubted the safety of vaccines more often than HSPs with almost no VH. Compared with non-hesitant HSPs, those with higher VH had less often taken a medical course about vaccination and were less likely to be vaccinated against seasonal influenza, to recommend vaccines to their patients and to try to convince vaccine-hesitant patients to be vaccinated.
Strong favorability to vaccination does not prevent VH, which was observed in most specialties. Interventions are required to help hesitant HSPs to adopt more proactive vaccination practices.
医疗保健专业人员因为向患者推荐疫苗、解答他们的问题并为其接种疫苗,是法国疫苗接种的基石。然而,他们也可能受到疫苗犹豫(VH)的影响。
我们旨在研究法国医院工作人员医师(HSPs)对疫苗的意见、实践和看法,以及他们中 VH 的流行情况及其相关因素。
我们于 2018 年 9 月至 2019 年 10 月在法国 14 家公立医院进行了一项横断面调查。HSPs 填写了一份关于他们疫苗相关态度和实践的标准化问卷-大多数情况下是面对面填写的。数据按年龄和性别进行加权。通过对 HSPs 对疫苗的看法和意见进行凝聚层次聚类分析,我们可以识别出疫苗犹豫的 HSPs,并通过稳健标准误差的多泊松回归来研究与 VH 相关的因素。
研究共纳入 1795 名 HSPs(参与率:86%)。几乎所有人(93.7%)都非常赞成接种疫苗,尽管 42.2%(95%CI=39.8-44.6)表现出中度 VH。VH 的流行率在传染病专家(12.3%;95%CI=6.7-21.3)和儿科医生(27.7%;95%CI=21.4-35.2)中最低。与非犹豫 HSPs 相比,犹豫 HSPs 对疫苗信息来源的信任度较低,对疫苗安全性的怀疑程度也较高。与非犹豫 HSPs 相比,VH 较高的 HSPs 较少接受过关于疫苗接种的医学课程,不太可能接种季节性流感疫苗,不太可能向患者推荐疫苗,也不太可能试图说服对疫苗犹豫不决的患者接种疫苗。
对疫苗的强烈赞成并不能预防 VH,这在大多数专科中都存在。需要采取干预措施,帮助犹豫的 HSPs 采取更积极主动的疫苗接种实践。